From Davison, Michigan, USA:
Over the past 5 to 10 years, I've read many studies that show that C-peptide reduces the occurrence of long-term complications in type 1 diabetics. The most recent article that I've read is C-peptide: new findings and therapeutic implications in diabetes. Why is C-peptide not being included in the treatment of type 1 diabetics when all of these studies show that it helps in the prevention of long-term complications?
C-peptide therapeutic research has been promoted for several decades, but there is no valid scientific data to suggest it has any benefit whatsoever over tight glucose control, current insulin regimens etc. in type 1 diabetes or in type 2 diabetes. Exactly what the function of C-peptide is physiologically is sometimes still debated scientifically but generally now well understood.
|Return to the Top of This Page|
Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.